Mon panier

Human CD33-coupled Magnetic Beads

Avis des utilisateurs
Numéro de produit/spécification
Prix
Availability
Qté
MBC-K008-2mg
$1070.00
MBC-K008-10mg (5mg X 2)
$3350.00
Total des articles Montant du produit$ 0

Détails du produit

  • Items
    Size 2mg
    Size 10mg (5mg × 2)
    Particle size
    2 μm
    2 μm
    Physical appearance
    Powder mixture
    Powder mixture
    Binding Capacity
    >267 pmol (40 μg) antibody/mg beads
    >267 pmol (40 μg) antibody/mg beads
    Formulation
    PBS, pH7.4, with 10% Trehalose
    PBS, pH7.4, with 10% Trehalose
    Reconstitution
    2 mL sterile deionized water (1 mg beads/mL)
    5 mL sterile deionized water (1 mg beads/mL)
  • Product Description

    The biotinylated CD33 protein was conjugated to streptavidin magnetic beads. This pre-coupled magnetic bead product can capture the anti-CD33 antibody from various assay systems. The beads are in uniform size, narrow size distribution with large surface area and unique surface coating, which can help you get the best performance and highly reproducible results. This CD33 coupled magnetic beads will bring great convenience with minimum non-specific binding and developed protocols. This ready-to-use product could greatly save your time and hassle.

  • Application

    This product is intended for immunocapture, biopanning. This is a non-sterile product.

    * The Isotype control (Cat. No. SMB-B01) is sold separately.

  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage

    Upon receipt, please store the beads at -20°C. The shelf life is 1 year at -20 °C.

    Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

  • Assay Principles

    Antibody Purification:
    1. Resuspend the lyophilized beads by adding the buffer of choice.
    2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.
    3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.
    4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.

    The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data

     Siglec-3 TYPICAL DATA

    Immobilized 53.7 μg CD33 protein to 1 mg Beads, can bind the Anti-CD33 Antibody with an EC50 of 0.7794 μg/mL.

    Protocol

Avis des utilisateurs
Publier un commentaire

FAQ

  • product

    Can lyophilized proteins remain stable during room-temperature shipping or temporary room-temperature exposure?

    In general, lyophilized proteins remain stable during room-temperature shipping or temporary exposure to room-temperature conditions.


    Many ACROBiosystems recombinant proteins are supplied in lyophilized (freeze-dried) form. The lyophilization process effectively removes moisture from the product, helping reduce degradation-related reactions and improve protein stability during transportation and storage.


    To evaluate the stability of lyophilized proteins under normal temperature conditions, ACROBiosystems conducted a stability study on 11 representative lyophilized protein products at 37°C. The study demonstrated that these proteins maintained good quality stability after storage at 37°C for approximately 20 days. Based on these validation results, temporary room-temperature exposure during shipping or handling is generally not expected to have a significant impact on product quality or downstream application performance.


    To ensure optimal long-term stability, products should be stored according to the storage conditions specified in the product Certificate of Analysis (COA) upon receipt.


    Supporting Document


Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Myeloid cell surface antigen CD33

  • Catégorie:

  • Nombre de médicaments répertoriés:

    1 Détails

  • Nombre de médicaments cliniques:

    44 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • FAQ